Literature DB >> 21580302

N-(Cyano-meth-yl)benzamide.

Younas Aouine, Anouar Alami, Abdelilah El Hallaoui, Abdelrhani Elachqar, Hafid Zouihri.   

Abstract

In the structure of the title compound, C(9)H(8)N(2)O, the amide group is twisted by a dihedral angle of 21.86 (7)° with respect to the benzene ring, while the planes of the benzene ring and cyano-methyl group form a dihedral angle of 53.13 (11)°. In the crystal structure, mol-ecules are linked via N-H⋯O hydrogen bonds, forming a chain running parallel to the a axis.

Entities:  

Year:  2010        PMID: 21580302      PMCID: PMC2983510          DOI: 10.1107/S1600536810003557

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity and medicinal properties of tetra­zole derivatives, see: Smissman et al. (1976 ▶); McGuire et al. (1990 ▶); Lunn et al. (1992 ▶); Itoh et al. (1995 ▶); Upadhayaya et al. (2004 ▶); Wu et al. (2008 ▶); Rostom et al. (2009 ▶); Burger (1991 ▶); Singh et al. (1980 ▶). For the synthetic procedure, see: Adams & Langley (1941a ▶,b ▶).

Experimental

Crystal data

C9H8N2O M = 160.17 Orthorhombic, a = 9.8623 (5) Å b = 8.0576 (4) Å c = 20.9268 (9) Å V = 1662.98 (14) Å3 Z = 8 Mo Kα radiation μ = 0.09 mm−1 T = 296 K 0.33 × 0.28 × 0.22 mm

Data collection

Bruker X8 APEXII CCD area-detector diffractometer 11132 measured reflections 1920 independent reflections 1433 reflections with I > 2σ(I) R int = 0.027

Refinement

R[F 2 > 2σ(F 2)] = 0.038 wR(F 2) = 0.109 S = 1.02 1920 reflections 141 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.14 e Å−3 Δρmin = −0.18 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: PLATON (Spek, 2009 ▶) and ORTEP-3 for Windows (Farrugia, 1997 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810003557/dn2533sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810003557/dn2533Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C9H8N2ODx = 1.280 Mg m3
Mr = 160.17Melting point: 413 K
Orthorhombic, PbcaMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ac 2abCell parameters from 3689 reflections
a = 9.8623 (5) Åθ = 2.5–27.2°
b = 8.0576 (4) ŵ = 0.09 mm1
c = 20.9268 (9) ÅT = 296 K
V = 1662.98 (14) Å3Block, colourless
Z = 80.33 × 0.28 × 0.22 mm
F(000) = 672
Bruker X8 APEXII CCD area-detector diffractometer1433 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.027
graphiteθmax = 27.6°, θmin = 2.8°
φ and ω scansh = −12→12
11132 measured reflectionsk = −10→10
1920 independent reflectionsl = −26→27
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.038Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.109H atoms treated by a mixture of independent and constrained refinement
S = 1.02w = 1/[σ2(Fo2) + (0.0541P)2 + 0.2439P] where P = (Fo2 + 2Fc2)/3
1920 reflections(Δ/σ)max < 0.001
141 parametersΔρmax = 0.14 e Å3
0 restraintsΔρmin = −0.18 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.24170 (14)0.39220 (16)0.13675 (7)0.0488 (3)
C20.25299 (17)0.43033 (18)0.07283 (7)0.0591 (4)
C30.36704 (17)0.38418 (18)0.03941 (7)0.0592 (4)
C40.47054 (16)0.30131 (19)0.06980 (7)0.0552 (4)
C50.46079 (13)0.26308 (16)0.13418 (6)0.0448 (3)
C60.34534 (11)0.30793 (14)0.16810 (6)0.0387 (3)
C70.32434 (11)0.26377 (15)0.23629 (6)0.0415 (3)
C80.41628 (14)0.17663 (17)0.33761 (6)0.0498 (3)
C90.37055 (14)0.31427 (19)0.37822 (6)0.0529 (3)
O10.21031 (8)0.25889 (15)0.26031 (5)0.0645 (3)
N10.43271 (11)0.22652 (14)0.27184 (5)0.0456 (3)
N20.33580 (17)0.4211 (2)0.40988 (7)0.0792 (4)
H10.1646 (16)0.4224 (18)0.1609 (7)0.064 (4)*
H20.1826 (17)0.489 (2)0.0525 (8)0.075 (5)*
H30.3723 (16)0.410 (2)−0.0064 (8)0.073 (5)*
H40.5496 (17)0.267 (2)0.0484 (8)0.067 (5)*
H50.5302 (16)0.2004 (18)0.1546 (7)0.054 (4)*
H60.5098 (18)0.2419 (17)0.2585 (7)0.053 (4)*
H70.5037 (17)0.1326 (19)0.3548 (8)0.065 (4)*
H80.3480 (15)0.0870 (17)0.3409 (7)0.057 (4)*
U11U22U33U12U13U23
C10.0411 (7)0.0482 (7)0.0571 (8)0.0051 (6)−0.0007 (6)0.0009 (6)
C20.0638 (9)0.0554 (8)0.0581 (8)0.0075 (7)−0.0087 (7)0.0066 (7)
C30.0733 (11)0.0587 (8)0.0457 (7)−0.0087 (8)−0.0014 (7)0.0005 (6)
C40.0508 (8)0.0631 (8)0.0517 (7)−0.0064 (7)0.0110 (6)−0.0100 (6)
C50.0333 (6)0.0512 (7)0.0500 (7)−0.0016 (5)0.0015 (5)−0.0043 (5)
C60.0290 (5)0.0400 (5)0.0470 (6)−0.0038 (5)−0.0013 (5)−0.0023 (5)
C70.0240 (5)0.0503 (6)0.0502 (7)−0.0016 (5)0.0027 (5)0.0016 (5)
C80.0373 (7)0.0564 (8)0.0558 (7)0.0041 (6)0.0010 (6)0.0149 (6)
C90.0435 (7)0.0665 (8)0.0487 (7)0.0021 (6)0.0020 (6)0.0156 (7)
O10.0224 (4)0.1126 (9)0.0586 (6)−0.0004 (5)0.0037 (4)0.0142 (5)
N10.0236 (5)0.0632 (7)0.0500 (6)−0.0002 (5)0.0027 (4)0.0093 (5)
N20.0867 (11)0.0836 (9)0.0675 (8)0.0108 (8)0.0100 (8)−0.0003 (7)
C1—C21.377 (2)C5—H50.952 (16)
C1—C61.3915 (17)C6—C71.4852 (17)
C1—H10.945 (16)C7—O11.2324 (13)
C2—C31.376 (2)C7—N11.3364 (15)
C2—H20.940 (18)C8—N11.4430 (17)
C3—H30.984 (16)C8—C91.468 (2)
C4—C31.376 (2)C8—H80.990 (15)
C4—H40.940 (17)C8—H70.999 (17)
C5—C41.3854 (19)C9—N21.1389 (19)
C5—C61.3896 (17)N1—H60.820 (17)
C5—C6—C1119.21 (12)N1—C8—H8110.2 (8)
C5—C6—C7122.87 (11)C9—C8—H8107.6 (8)
C1—C6—C7117.86 (11)N1—C8—H7110.2 (9)
O1—C7—N1119.70 (11)C9—C8—H7109.0 (9)
O1—C7—C6121.79 (11)H8—C8—H7107.6 (12)
N1—C7—C6118.50 (10)N2—C9—C8179.61 (18)
C4—C5—C6119.72 (13)C3—C2—C1119.98 (14)
C4—C5—H5120.3 (9)C3—C2—H2120.6 (10)
C6—C5—H5119.9 (9)C1—C2—H2119.4 (10)
C3—C4—C5120.40 (14)C4—C3—C2120.20 (14)
C3—C4—H4122.4 (10)C4—C3—H3121.1 (10)
C5—C4—H4117.2 (10)C2—C3—H3118.7 (9)
C2—C1—C6120.49 (13)C7—N1—C8120.25 (11)
C2—C1—H1121.8 (9)C7—N1—H6121.2 (11)
C6—C1—H1117.7 (9)C8—N1—H6118.2 (11)
N1—C8—C9112.10 (11)
D—H···AD—HH···AD···AD—H···A
N1—H6···O1i0.819 (17)2.021 (18)2.8313 (14)169
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H6⋯O1i0.819 (17)2.021 (18)2.8313 (14)169

Symmetry code: (i) .

  11 in total

1.  Synthesis of novel substituted tetrazoles having antifungal activity.

Authors:  Ram Shankar Upadhayaya; Sanjay Jain; Neelima Sinha; Nawal Kishore; Ramesh Chandra; Sudershan K Arora
Journal:  Eur J Med Chem       Date:  2004-07       Impact factor: 6.514

Review 2.  Isosterism and bioisosterism in drug design.

Authors:  A Burger
Journal:  Prog Drug Res       Date:  1991

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Synthesis of inhibitors of bacterial cell wall biogenesis. Analogs of D-alanyl-D-alanine.

Authors:  E E Smissman; A Terada; S El-Antably
Journal:  J Med Chem       Date:  1976-01       Impact factor: 7.446

Review 5.  Medicinal chemistry of tetrazoles.

Authors:  H Singh; A S Chawla; V K Kapoor; D Paul; R K Malhotra
Journal:  Prog Med Chem       Date:  1980

6.  Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. I: Synthesis and biological properties of pyrrolo[2,3-d]pyrimidine antifolates containing tetrazole congener of glutamic acid.

Authors:  F Itoh; K Yukishige; M Wajima; K Ootsu; H Akimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-02       Impact factor: 1.645

7.  Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.

Authors:  J J McGuire; C A Russell; W E Bolanowska; C M Freitag; C S Jones; T I Kalman
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

8.  DL-tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy.

Authors:  W H Lunn; D D Schoepp; D O Calligaro; R T Vasileff; L J Heinz; C R Salhoff; P J O'Malley
Journal:  J Med Chem       Date:  1992-11-27       Impact factor: 7.446

9.  Azole antimicrobial pharmacophore-based tetrazoles: synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents.

Authors:  Sherif A F Rostom; Hayam M A Ashour; Heba A Abd El Razik; Abd El Fattah H Abd El Fattah; Nagwa N El-Din
Journal:  Bioorg Med Chem       Date:  2009-02-08       Impact factor: 3.641

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.